Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 26, 2021
[Amantadine in the treatment of Parkinson's disease. New opportunities in the context of COVID-19]E A KatuninaEksperimental'Naia I Klinicheskaia Farmakologiia|November 10, 2005
[Estimating the potential of antioxidant therapy for patients with Parkinson's disease diagnosis]E A KatuninaZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 5, 2014
[Levodopa: the story continues]N V Titova, E A KatuninaZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 15, 2015
[Current possibilities of quality of life improvement in the late stages of Parkinson's disease]N V Titova, E A KatuninaZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 29, 2022
[Mechanisms of development of constipation in Parkinson's disease and therapeutic approaches]E A Katunina, N N Shipilova, D A KatuninZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 23, 2024
[The complex effect of polyphenols on the gut microbiota and triggers of neurodegeneration in Parkinson's disease]E A Katunina, A M Semenova, D A KatuninZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 14, 2023
[Asthenia, mental fatigue and cognitive dysfunction]N V Titova, Yu N Bezdolny, E A KatuninaZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 8, 2016
[Comorbid states in Parkinson's disease: an effect of MAO-B inhibitors]N V Titova, E A Katunina, N N SotnikovaZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 12, 2025
[Art and creativity in Parkinson's disease: the mysterious effects of dopamine]E A Katunina, Z A Zalyalova, D V Pokhabov, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 14, 2019
[Approaches to early diagnosis of Parkinson's disease]E A Katunina, E P Ilina, G A Sadekhova, et al.Pageof 4